Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act

Robert W. Burgoyne; Darrell H. S. Tan
March 2008
Journal of Antimicrobial Chemotherapy (JAC);Mar2008, Vol. 61 Issue 3, p469
Academic Journal
Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities, one of the Achilles’ heels of HAART. This article reviews research findings on treatment and QOL outcomes a decade into the HAART era.


Related Articles

  • Editorial Commentary: Addressing Disparities in HIV Mortality: Antiretroviral Therapy Is Necessary but Not Sufficient. Smith, Kimberly Y. // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1810 

    An introduction is presented in which the editor discusses the study which examines the influence of geographic origin and race/ethnicity on HIV mortality in patients on antiretroviral therapy (ART) in Canada, Europe, and the U.S.

  • HIV-positive people on ART have the same mortality risk to HIV-negative people.  // HIV Australia;2013, Vol. 11 Issue 2, p5 

    The article presents information on a report according to which HIV-positive persons responding well to antiretroviral therapy have no higher mortality risk as compared to their HIV-negative peers.

  • Validation of the Medical Outcomes Study HIV Health Survey as a measure of quality of life in HIV-infected patients in Singapore. Paton, Nicholas I.; Chapman, Chere A. T.; Siew-Pang Chan; Tan, Karen M.; Leo, Yee-Sin; Aboulhab, Jamila; Chang-Heok SohK; Chan, Siew-Pang; Soh, Chang-Heok // International Journal of STD & AIDS;Jul2002, Vol. 13 Issue 7, p456 

    Measurement of quality of life is crucial to assess the full impact of antiretroviral therapy on patient morbidity. No quality of life instruments have been validated in an Asian HIV-infected patient population, but it is important to do so given the increasing involvement of the region in...

  • DREAMS TO REALITY COMES TO NASHVILLE. GRADY, JAMES // Out & About;Aug2014, Vol. 13 Issue 8, p28 

    The article offers information on the people with HIV positive disease with the emergence of symptoms in Nashville, Tennessee. It focuses on the rise of antiretroviral treatments and life enhancing measures that extends the lives of people living with the disease and improved their quality of...

  • The Medication Attribution Scale: Perceived Effects of Antiretrovirals and Quality of Life. Aversa, A.; Kimberlin, C.; Segal, R. // Quality of Life Research;May1998, Vol. 7 Issue 3, p205 

    This report describes the development and validation of an instrument to assess the attributions human immunodeficiency virus (HIV)-infected persons who are currently taking antiretrovirals make about the effects of these medications. The specific limitations in functioning that the subjects...

  • Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study. Panos, George; Samonis, George; Alexiou, Vangelis G.; Kavarnou, Garyfallia A.; Charatsis, Gerasimos; Falagas, Matthew E. // Current HIV Research;May2008, Vol. 6 Issue 3, p257 

    HAART has substantially decreased mortality and morbidity among HIV-infected patients. We retrospectively analyzed morbidity and mortality in a cohort of HIV-infected adult patients with prolonged and frequent follow up (1987-2006). The study was divided in pre-HAART and HAART period for...

  • Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study.  // AIDS Research & Therapy;2012, Vol. 9, p15 

    The article offers information regarding a study which aimed to examine mortality and its predictors among a cohort of HIV infected patients on anti-retroviral treatment retrospectively followed for five years in Ethiopia. As reported, a total of 1540 study participants were included. As stated,...

  • Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatient's at a Community Care Center. Rajagopalan, Nirmala; Suchitra, Joyce B.; Shet, Anita; Khan, Zafar K.; Martin-Garcia, Julio; Nonnemacher, Michael R.; Jacobson, Jeffrey M.; Wigdahl, Brian // American Journal of Infectious Diseases;2009, Vol. 5 Issue 3, p219 

    Problem statement: Despite massive national efforts to scale up Antiretroviral Therapy (ART) access in India since 2004, the AIDS death rate was 17.2 per 100,000 persons during 2003- 2005. In the era of HAART in resource poor settings, it is imperative to understand and address the causes of...

  • Sensitivity of chronically HIV-1 infected HeLa cells to electrical stimulation. Kumagai, E.; Tominaga, M.; Harada, S. // Applied Microbiology & Biotechnology;Feb2004, Vol. 63 Issue 6, p754 

    Use of combination anti-retroviral drug regimens including protease inhibitors dramatically decreased morbidity and mortality rates in HIV-1 infected individuals. However, such combination therapies appear to have many side effects, in addition to the emergence of resistant HIV-1 strains....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics